Berchuck A, Kohler M F, Boente M P, Rodriguez G C, Whitaker R S, Bast R C
Department of Obstetrics and Gynecology, Duke Comprehensive Cancer Center, Durham, North Carolina.
Cancer. 1993 Jan 15;71(2 Suppl):545-51. doi: 10.1002/cncr.2820710209.
The discovery of peptide growth factors and cancer-causing genes (oncogenes and tumor-suppressor genes) has provided us with the exciting opportunity to begin to understand the molecular pathology of human ovarian cancer. Activation of several genes, including HER-2/neu, myc, ras, and p53 have been described in some ovarian cancers. In addition, some protooncogenes such as the epidermal growth factor receptor (erbB) and the M-CSF receptor (fms) are expressed along with the respective ligands (peptide growth factors) in some ovarian cancers. Although the studies reviewed in this paper represent a promising beginning, we remain far from a comprehensive understanding of growth regulation and transformation of human ovarian epithelium.
肽生长因子和致癌基因(癌基因和肿瘤抑制基因)的发现,为我们提供了令人振奋的机会,使我们能够开始了解人类卵巢癌的分子病理学。在某些卵巢癌中,已发现包括HER-2/neu、myc、ras和p53在内的多个基因被激活。此外,一些原癌基因,如表皮生长因子受体(erbB)和M-CSF受体(fms),在某些卵巢癌中与各自的配体(肽生长因子)一起表达。尽管本文所综述的研究是一个有前景的开端,但我们距离全面了解人类卵巢上皮细胞的生长调节和转化仍有很大差距。